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ABSTRACT  Efficient  binding of  native,  soluble  1251-labeled  type  I  rat collagen  to  mouse  3T3 
fibroblast monolayers requires prior warming of the ligand to 35-37°C for 10-30 min. Decreased 
binding at high  ligand concentrations is ascribed  to  ligand-ligand interactions rather than to 
negative cooperativity. Addition of  bacterial collagenase to  monolayers labeled with the 12sI- 
ligand  releases a  constant  fraction  (80%)  of  the  bound  ligand  over  a  2-h  interval  at  37°C, 
indicating that  little of  the  ligand  becomes  inaccessible by  pinocytosis. Colchicine  (10  -~  M) 
and  vinblastine  (5  x  10 -8  M)  do  not  inhibit  binding  by  morphologically  intact  monolayers. 
Cytochalasins and concanavalin A show dose-related inhibition of binding by intact monolayers 
that is due to a reduction  in the number of available binding sites rather than to a change in 
binding  site  affinity.  The  collagen  binding  site  on  the  fibroblast  surface  is  proposed  as  an 
organizing center for the assembly of periodic type I collagen fibrils. 
Collagens, collagen ot chains, and collagenous peptides bind to 
the surface of fibroblasts. Chiang et al. have reported that heat- 
denatured collagenous molecules bind to the fibroblast surface 
and  induce chemotactic migration of the cells  in vitro  (1).  I 
have  studied  the  binding  of native  soluble  collagen  to  the 
fibroblast and have suggested that polymerization of collagen 
to form fibrils might be initiated upon the cell surface (2). To 
gain further insights into functions of surface-bound collagens, 
I examined in additional detail the binding of native, soluble 
'2'~I-labeled type I collagen to fibroblasts.  In particular,  I ana- 
lyzed the requirement for thermal activation of the ligand, the 
effect on binding of ligand concentration, and pinocytosis of 
the bound ligand.  A  variety of molecules that could interact 
with the ligand at the cell surface, alter fibroblast metabolism, 
or alter cell membrane or cytoskeletal architecture  have also 
been tested for possible effects on collagen binding. These data 
are interpreted  in terms of the proposal that a  plasma mem- 
brane binding site participates in the initial assembly of colla- 
gen fibrils. 
MATERIALS  AND  METHODS 
Cells and Binding Assay 
The contact-inhibited 3T3  Swiss mouse fibroblast line was cultured in Dul- 
becco's modification of Eagle's medium (DME) with 10% calf serum, lodinated 
lathyritic rat skin collagen (~zr'I-LRSC) was prepared as previously described (2). 
Freshly prepared ligand stock solutions had specific activities of ~3 ×  10" cpm/ 
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#g, For experiments, the ~2SI-LRSC stock was diluted with binding buffer (DME 
with half bicarbonate concentration, 0.05  M  HEPES,  pH  7.2  and 2,5  mg/ml 
bovine serum albumin) to -60,000 cpm/ml and warmed at 37°C for 30 min. 
Confluent 3T3  monolayers in 60-ram plastic petri dishes (-2  x  106 ceils) were 
washed three times with 4 ml of binding buffer before receiving 2 ml of the heat- 
activated ~2~I-LRSC solution that had been cooled to room temperature (26°C). 
Binding  studies  were  generally performed  at  the  latter  temperature.  Rapid 
washing of the cultures and measurement of radioactivity specifically bound to 
the ceils were performed as described (2). 
Protease Digestions: Probes for Triple-Helicity 
of Collagen 
Native soluble unlabeled LRSC, or t4C-(proline and glycine)-labeled  lathyrific 
type 1 mouse collagen, was incubated at 37°C for 30 rain ("thermal activation"), 
or  kept  at  4°C  (controls) before  incubation  with  proteases.  Three  digestion 
protocols were used. (a) Digestion with pepsin (Worthington Biochemical Corp.. 
Freehold, N J; Porcine A), 100/tg/ml in 0.5 M acetic acid. Enzyme/substrate ratio 
1/10.  Incubation at  15°C for 5 h.  Reaction stopped with cooling, addition of 
pepstatin, and NaOH. (b) Digestion with a-chymotrypsin (Worthington Biochem- 
ical Corp.: CDI), according to Bornstein et al. (3). Enzyme/substrate ratio I/[0. 
Incubation at 15°C for 24 h. Reaction stopped by cooling, acidification, addition 
of leupeptin and pepstatin, and salt-precipitation of the collagen. (c) Digestion 
with mixture of Trypsin (Worthington Biochemical Corp.:  TRTPCK)  and a- 
chymotrypsin, according to Bruckner and Prockop (4).  Trypsin:  10-fold  molar 
excess: chymotrypsin: 100-fold  molar excess: relative to substrate. Incubation at 
20°C for 3-15  min. Reaction stopped by cooling, addition of soybean trypsin 
inhibitor (Sigma Chemical Co., St. Louis, MO), r-(I-tosylamido-2-phenyl)ethyl 
chloromethyl ketone (Sigma Chemical Co.: TPCK),  urea, SDS, and heating at 
100°C for 3 min. 
The products of digestion were analyzed by electrophoresis in SDS polyacryl- 
747 amide slab gels. Proteins were visualized by Coomassie Blue staining or fluorog- 
raphy. Resistance to proteolysis was assessed by the relative recoveries of intact 
helical a chains from experimental and control digests. 
Materials 
Lathyritic rat  skin collagen was donated  by Dr.  George Martin  (National 
Institute of Dental Research, Bethesda, MD). Heparinase was provided by Dr. 
Alfred Linker (VA Hospital, Salt Lake City, UT). Reference glycosaminoglycans 
were obtained from Dr. M. B. Mathews and J. A. CifoneUi (Dept. of Pediatrics, 
University of  Chicago, Chicago, ILj. Reagents were purchased from the following 
suppliers: steroids, prostaglandins, cholera toxin, dibutyryl cyclic AMP, cyclic 
AMP, dibutyryl cyclic GMP, cyclic GMP, cyclo eximid¢ and concanavalin A 
from Sigma Chemical Co., St. Louis, MO; coliagenase, form III, from Advance 
Biofactors, Lynbrook, Long Island, NY; lonomycin from Dr. Edward Meyers, 
Squibb Institute for Medical Research, Princeton, N  J; A23187 from Calbiochem- 
Behring Corp., La Jolla, CL; cytochalasins from Aldrich, Milwaukee, WI; col- 
chicine and vinblastine from Eli Lilly, Indianapolis, IN; gangliosides and cer- 
amides from Supelco, BeUefonte, PA; isoproterenol hydrochloride from Winthrop 
Laboratories, New York, NY; and propranolol hydrochloride from Ayerst Lab, 
South Plainfield, NJ. 
RESULTS 
Thermal Activation of the Ligand 
If aliquots of the cold r>5I-LRSC  stock solution are diluted 
into binding buffer and  if binding studies are performed di- 
rectly with that solution at 26°C, <0.5% of the input radioac- 
tivity will bind to fibroblasts. By contrast, if the ligand solution 
is preincubated at 37°C for 30 min, cooled to 26°C and then 
presented  to  the  cells,  ~10%  of  the  input  radioactivity is 
specifically  bound. Fig. 1 shows the effect on ligand binding of 
30-rain preincubations at different temperatures. It is evident 
that  the  ligand  must  be  warmed  above  35°C  to  promote 
significant binding and  that binding is maximized when  the 
ligand  is  heated  to  42°C.  Above  37°C,  lathyritic  rat  skin 
collagen in  dilute solution will begin to  melt (5),  i.e., chain 
separation will occur and the native triple helical molecule will 
be converted to random coil gelatin. Because the aim of the 
study  was  to  examine  the  binding  of  the  native  collagen 
molecule, 37°C  was chosen  as the  standard  temperature for 
thermal  activation of the  ligand.  The  experiment  of Fig.  2 
shows that the binding capacity of the ligand increases rapidly 
during  the  initial  10  min  of incubation  at  37°C  and  that  it 
approaches a constant value after 30 min. Thermal activation 
is not reversed by subsequently keeping the ligand at 4°C for 
several hours  because ligand so treated does not  require re- 
heating to 37°C to bind efficiently to cells. Thus, routinely for 
binding studies, the 125I-LRSC was diluted with binding buffer 
to  a  concentration of 10-20 ng/ml,  incubated  for 30  min  at 
37°C, cooled to 26°C, and cell binding studies were performed 
at the latter temperature. 
Triple-helical collagen resists proteolytic digestion. To assess 
the native helicity of collagen activated at 37°C, I compared its 
resistance to proteolysis to that of native, unwarmed  control 
substrates. Three different digestion protocols were used (see 
Materials and Methods); in each case the activated and control 
FIGURE  1  Effect  of  temperature 
ff 
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TEMPERATURE  (°C) 
on  binding  capacity  of  ligand. 
Stock 12~I-LRSC was diluted with 
binding  buffer  to  give 6.3  x  104 
cpm/ml  and  heated  at different 
temperatures  for  30  min.  After 
cooling  to  26°C,  2  ml  of  ligand 
solutions were added to each cul- 
ture plate of 3T3  fibroblasts (2  x 
106  cells).  Specific  binding  was 
measured after 2 h at 26°C. 
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substrates  were  equally  resistant  to  proteolysis  (data  not 
shown). Thermal activation of the ligand could thus be ascribed 
to two processes: (a) conformational changes within a molecule 
that remains triple helical; and (b) assembly ofligand molecules 
into  larger aggregates. Process a  is probably independent of 
ligand concentration, whereas the rate of process b is known to 
be directly proportional to the concentration of collagen (6-8). 
To determine which of these processes is responsible for ther- 
mal activation, I  warmed  E2'~I-LRSC solutions at  14.2 ~g/ml 
and at 12.7 ng/ml, respectively, at 37°C for 30 min. The more 
concentrated solution was then diluted to  12.7 ng/ml.  Equal 
amounts of the respective ligand preparations were then added 
to replicate fibroblast cultures and specific binding with time 
was measured.  Fig.  3  shows  that  both  ligands bound  to  the 
fibroblasts but that the ligand activated at the i,000-fold lower 
concentration bound more efficiently. This result suggests that 
conformational changes in the molecule are probably the basis 
for ligand activation and that polymerization of ligand beyond 
some limiting size results in less efficient binding. 
Effect of Ligand Concentration on Binding 
Collagen binding to fibroblasts is a saturable process (2) but 
addition of collagen in excess of saturating amounts apparently 
decreases the total amount of specifically bound collagen. This 
is shown by the following experiment. Cultures received a fixed 
amount  of 12~I-LRSC  and  increasing  amounts  of unlabeled 
LRSC. The cultures were incubated at 26°C for 2 h to achieve 
binding  equilibrium,  the  amount  of  12'~I-LRSC bound  was 
measured,  and  the  total  amount  of labeled  and  unlabeled 
ligand specifically bound  to  the  cells was  calculated. Fig. 4 
shows that saturation was approached after addition of 70 pm 
(20/~g) of unlabeled collagen but that addition of 140 pm of 
collagen caused the total amount of bound collagen to decrease 
by 20%. In hormone-receptor systems, such enhanced dissocia- 
tion  at  high  ligand  concentrations  is  well  known,  and  the 
phenomenon  has been variously ascribed to experimental ar- 
tifacts or to  biologically relevant cooperative interations be- 
tween  receptor sites (see reference 9  for general discussion). 
Ligand-ligand aggregation is one experimental cause  for the 
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FIGURE  2  Time dependency of thermal 
activation  of  ligand.  12SI-LRSC was  di- 
luted  with  binding  buffer  to  6.1  ×  104 
cpm/ml  and  incubated  at 37°C  for the 
indicated times. The respective solutions 
of ligand were then cooled to 26°C, 2 m[ 
of each solution was added to replicate 
3T3 cultures (3 X  10  e cells), and specific 
binding was measured after 2-h incuba- 
tions at 26°C. 
'~ '5/r  ..~~  FIGURE 3  Effect of ligand concentration 
~i0  on  thermal  activation.  ~2SI-LRSC stock  [  f~  i[  ,/'~/,~,  ,  ,  ,  ,  (14.2/~g/ml)  was heated at 37°C  for 30 
rain and then diluted into binding buffer 
to  12.7 ng/ml  (O).  12~I-LRSC stock was 
o  15  ~o  ~  ~  ~  go  diluted to12.7 ng/ml with binding buffer 
=mUtES  and then heated at 37°C for 30 min (0). 
Replicate cultures received 2 ml  (1.2 x  10  s cpm) of the respective 
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FiGure  4  Binding  as  a  function  of 
ligand  concentration.  Increasing 
amounts  of  unlabeled  LRSC (0-100 
/~g)  were  premixed  with  a  fixed 
amount of ~251-LRSC (1.38 x  105 cpm) 
in 2 ml  of binding  buffer. After acti- 
vation at 37°C for 30 min,  the solu- 
tions were added to replicate cultures 
and  binding was measured after 2 h 
at  26°C.  The  picomoles  of  collagen 
added  (radiolabeled and  unlabeled) 
and specifically bound  (radiolabeled 
and unlabeled) were then computed. 
given  that  molecule's propensity for  polymerization.  In  the 
experiment of Fig. 4,  it is likely that  some degree of ligand 
aggregation  occurred  at  the  highest concentration  of added 
unlabeled collagen (20 #g/ml), both during the 30-min activa- 
tion step at 37°C  and during the 2-h incubation with cells at 
26°C. 
Negative  cooperativity is  generally  ascribed  to  allosteric 
interactions between mobile receptors, and thus such interac- 
tions should be diminished or abolished in cells treated with 
cross-linking aldehydic fLxatives.  To  the  degree  that  an  en- 
hanced off-rate by added excess ligand depends upon negative 
cooperativity, the enhanced off-rate should be diminished in 
fixed cells.  3T3  fibroblasts fLxed for  15  min  at  26°C  in  2% 
buffered  paraformaldehyde will specifically bind  r~'~I-LRSC 
but binding is reduced by 80% and the off-rate in the absence 
of added LRSC is somewhat increased as compared to unfLxed 
cells. However, the addition of excess (100/lg) unlabeled LRSC 
to labeled fixed cells enhances the off-rate to the same relative 
degree as for labeled unfLxed cells (data not shown). Thus, the 
evidence does not favor negative cooperativity as an important 
mechanism for enhanced dissociation in the collagen binding 
system. 
Test for Pinocytosis of Ligand 
About 80% of the ~251-LRSC bound to fibroblasts is removed 
when the cells are incubated with 270 U of bacterial collagenase 
for 15 min at 37°C. Cell layer morphology is unaltered by this 
treatment. Reasoning that pinocytosis of bound ligand should 
decrease the amount of radioactivity released by collagenase, 
I performed the following experiment. Fibroblasts were incu- 
bated with ~25I-LRSC for 60 min at 26°C, unbound ligand was 
removed by washing, and the cultures were then incubated in 
binding buffer at 37°C  for 2 h.  At intervals, replicate plates 
received collagenase as described above, and  the amount  of 
bound radioactivity remaining in these and control plates was 
measured. The data are presented in Fig. 5. The off-rate of the 
~25I-LRSC  in  the  control  plates is  greater  than  the  off-rate 
recorded for cultures maintained at 26°C (2). This means that 
if the shift from 26 ° to 37°C after binding stimulated pinocy- 
tosis of 12~I-LRSC,  the effect was outweighed by a  relatively 
greater increase in the dissociation rate of the ligand. Moreover, 
the  data of Fig.  5  show  that  throughout  the  2-h  "chase"  at 
37°C  the  fraction  of bound  ligand  released  by  collagenase 
remained constant (-80%). Thus, with time, the bound ligand 
did not become less accessible to added collagenase and,  by 
this  criterion,  significant  pinocytosis  of the  ligand  did  not 
occur. Moreover, that fraction of radioactive ligand that was 
not  released by the  short  incubation with  collagenase could 
also have been bound to the cell surface. 
Binding and Metabolism of the Fibroblast 
The plasma membrane component which binds to the col- 
lagen has not been identified. By the following tests, the ligand 
does not appear to bind to collagens, glycosaminoglycans, or 
gangliosides on the surface of the fibroblast. (a) The rate and 
amount  of ligand binding are unchanged when  the cells are 
pretreated with bacterial collagenase, chondroitinase ABC or 
testicular hyaluronidase (2).  (b) Pretreatment of 2  x  106 3T3 
fibroblasts with 100/~g/ml of crude heparinase for 1 h at 37°C 
does not alter the binding reaction. (c) Addition to the cultures 
of 40 #g of hyaluronate, chondroitin 4-sulfate, chondroitin 6- 
sulfate,  dermatan  sulfate,  type  II  keratan  sulfate,  heparin, 
heparan sulfate, ceramides, or gangliosides (Gwg GDIa; or Gin1), 
respectively, does not alter binding. 
A variety of agents that modify fibroblast metabolism were 
tested for possible effects on  the  binding reaction (Table I). 
The  agents  were  applied  under  conditions  which  allowed 
expression of their metabolic actions but which did not alter 
cell layer morphology, as judged by phase microscopy. None 
of the listed agents altered the binding of 125I-LRSC (data not 
shown) when compared to control cells. 
Although the microtubule modifying agents, colchicine and 
vinblastine, were without effect, the microfilament modifiers, 
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FIGUre  5  Accessibility of bound 
ligand to added collagenase. Rep- 
licate  cultures were  labeled with 
1251-LRSC (1.3  x  105 cpm)  for 60 
min  at  26°C,  washed,  and  then 
incubated  with  2  ml  of  binding 
buffer at  37°C.  At  invervals, one 
set of cultures  received 270  U  of 
bacterial collagenase for 15 min.  Radioactivity bound to cell  layers 
in  control  cultures,  (0)  and  collagenase-treated cultures  (O)  was 
then measured. 
TABLE  I 
Agents Added to Fibroblast  Cultures 
Concentration  Preincubation 
Hours at 37°C 
Hydrocortisone  2 X  10  -5 M  18 
Cortisone  10  -5 M  18 
Prednisolone  10  -5 M  18 
Dexamethasone  2 x  10  -~ M  18 
Testosterone  10  -5 M  18 
fl-estradiol  10  -5 M  18 
Arachidonic acid  1/~g/ml  1 
Prostaglandins (El,  E2, F2,)  1 p,g/ml  1 
Cholera toxin  0.5/Lg/ml  18 
Dibutyry[ cyclic AMP  1 mM  18 
Cyclic AMP  1 mM  18 
Dibutyryl cyclic GMP  0.25 mM  18 
Cyclic GMP  1 mM  18 
Isoproterenol  2.5/~g/ml  18 
Propranolol  0.5 #g/ml  18 
Ionophores: 
ionomycin  5 p.M  1 
A23187  15 p.M  1 
Colchicine  10  -r M  2 
Vinblastine sulfate  5 x  10  -s M  2 
Cycloheximide  25 #g/ml  18 
After preincubations, standard 2-h binding assays  were performed with the 
drugs present at the indicated concentrations. 
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90 min at 37°C, and the drugs were also present during the 
subsequent 2-h incubation with L2~I-LRSC at 25°C. At cyto- 
chalasin concentrations above 2.5 gg/ml, significant cell de- 
tachment occurred. At lower concentrations, some cell retrac- 
tion and rounding without detachment occurred. At cytochal- 
asin concentrations below  1 gg/ml the morphologic changes 
were minimal.  Table II shows a comparison between the effects 
of the lower concentrations of the two cytochalasins on the 
morphology of the cell layers and the binding reaction. It is 
evident  that  cytochalasin D  is  the  more  potent  drug  with 
respect to both altering cell morphology and inhibiting  binding. 
The lectin concanavalin  A interacts with carbohydrate moie- 
ties  of membrane macromolecules,  causing changes  in  the 
surface properties of ceils (reference  10,  for general review). 
3T3 fibroblasts were incubated with different concentrations  of 
concanavalin  A, and a dose-dependent inhibition  of I2SI-LRSC 
binding was demonstrated (Fig. 6). To determine whether the 
addition of concanavalin A reduced the number or affinity of 
the binding sites,  I  pretreated the ceils with  8/~g/ml of the 
lectin and then incubated the cells in its presence with  ~25I- 
LRSC  and various concentrations of unlabeled LRSC,  and 
then  I  analyzed ligand binding by a  Scatchard  plot.  Fig.  7 
shows that control and concanavalin-treated ceils gave lines 
with similar slopes but that less ligand was bound at saturation 
TABLE  II 
Effects  of Microfilament Modifiers 
Concentra-  Cell retraction  Inhibition  of 
tion  and rounding  binding 
~g/ml  % 
Cytochalasin B  2.5  ++  22.8 
1.o  +-  o 
Cytochalasin D  1.0  ++  68.4 
0.5  +-  50.0 






FIGURE  6  Inhibition  of  binding  by 
concanavalin  A.  Replicate  cultures 
were incubated with  increasing con- 
centrations  of  concanavalin  A  in 
binding  buffer  for  60  rain  at  37°C. 
Washed cultures  then  received acti- 
vated 12SI-LRSC (1.3 x  105 cpm}  and 
corresponding concentrations of con- 
canavalin  A  in  binding  buffer.  The 
cultures  were  incubated  for  2  h  at  CONCANAVALIN A  (~.g/ml) 
26°C and specific binding was measured. Data are plotted as percent 
inhibition of binding measured in  replicate control  plates that did 
not receive concanavalin A. 
in the concanavalin-treated system. This result indicates that 
concanavalin  caused a reduction in the number of binding  sites 
without altering their afffmity. A  similar result was obtained 
when a Scatchard plot of cytochalasin D inhibition of binding 
at 0.5 p.g/ml was performed (data not shown). 
DISCUSSION 
The I2SI-LRSC activated for binding by preincubation at 37°C 
for  30  min resists  limited digestion with  proteases.  By  this 
criterion the  activated ligand retains triple helical structure. 
The warming requirement is not a consequence of radioiodi- 
nation of the molecule because unlabeled LRSC also requires 
thermal activation to compete effectively for binding sites  in 
inhibition  assays (1 l). I judge that warming of the ligand at the 
physiologic  temperature  induces  subtle  conformational 
changes that do not include misalignment  or separation of the 
three helical a  chains. Activation of the ligand was routinely 
performed in highly dilute solutions (10-20 ng/ml). Ligand 
activated at a 1,000-fold greater concentration  bound somewhat 
less well to fibroblasts. Warming at the higher concentration 
may have promoted polymerization  of the ligand, and the latter 
process could have reversed conformational changes in indi- 
vidual molecules or produced molecular aggregates with de- 
creased affinities for binding sites. Such ligand-ligand interac- 
tions rather than negative cooperativity are thought to be the 
basis for the decrease in total binding when a large excess  of 
unlabeled collagen is added  to  the  cultures as  in Fig.  4.  In 
Scatchard analyses, I have disregarded such anomalous data 
points and have derived the binding constants from a  single 
straight line fit. From such plots the KA approximates 10S/M, 
and about 5  ×  l0  s binding sites  per cell are calculated. For 
comparison, insulin binds to the fibroblast at 24°C with a KA 
of 109/M, but only 4 x  l03 molecules of hormone bind per cell 
at saturation (12). Even with the large number of binding sites 
for collagen, I calculate that at saturation, no more than 8% of 
the surface area of the 3T3 fibroblast is covered by collagen) 
Collagen bound to the fibroblast surface dissociates at a very 
slow rate. The half-life of the bound complex at 26°C is about 
2.5 h and, at 37°C, 46 min (2). Although remaining upon the 
cell surface for relatively long periods, the ligand is not actively 
pinocytosed, as judged by the test of undiminished  accessibility 
to added collagenase. 
The evidence does not favor the view that r'SI-LRSC binds 
to collagens, hyaluronate, or proteoglycans coating the fibro- 
blast surface. Nor is the binding  blocked by added gangliosides 
or ceramides.  The soluble native ligand does  not appear  to 
bind to fibronectin on the cell surface (2, 11). The presumption 
is  that  the  ligand binds to  a  still unidentified glycoprotein 
component of the plasma membrane. 
A possible function for collagen binding could be the initi- 
ation of biochemical reactions which ultimately help regulate 
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FIGURE  7  Scatchard  plot 
of  binding  data  in  pres- 
ence  and  absence of  con- 
canavalin  A.  Increasing 
amounts  of  unlabeled 
LRSC were  premixed  with 
fixed amounts of 12SI-LRSC 
and  presented  to  cells 
(same conditions as for ex- 
periment  of  Fig.  4).  One  set  of  plates  (C))  received  8  /tg/m[  of 
concanavalin  A  1  h  before  and  during  the  2-h  labeling  interval. 
Control cultures (ll  L 
' Computed to give a minimum for the surface area of the fibroblast 
and a maximum for the area covered by collagen. Measurements were 
made of 3T3 ceils at confluence. The cell shape was assumed to be 
rectangular; irregular or long cytoplasmic  projections were ignored and 
the two dimensions were taken from the main cell area. The average 
cell area calculated was 2.7 × 10-~cm  2. Collagen was assumed to bind 
only to the fibroblast surface away from the plastic substrate. Only one 
collagen molecule was assumed to bind by its entire lateral surface to 
each cell binding  site. The collagen surface in contact with the cell was 
considered to be a rectangle with the dimensions 1.5 x  300 nm. At 
saturation, collagen would thus cover an area of 2.25 ×  10-6cm  2, or 
approximately 8 per cent of the computed surface area. 
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functional  linkages,  the  fibroblasts  were  treated  with  several 
agents (Table I) which modulate collagen synthesis, turnover, 
and secretion (13-18), but none of the drugs altered the amount 
of bound ligand. The finding that binding was not diminished 
even after  18-h exposure to cycloheximide  indicates  that  the 
cell binding site is not subject to significant turnover in growth- 
inhibited 3T3 fibroblasts. 
The observation that collagen binding is inhibited by cyto- 
chalasins and concanavalin A  can be interpreted  in terms of 
the known effects of these agents on classical surface receptors. 
For example, Van Obberghen et al. reported that cytochalasins 
A  and B decreased the binding of insulin and human growth 
hormone to human  lymphocytes  and  that  such  binding  was 
unaffected  by colchicine  and vinblastine.  As in  the  case  for 
collagen  binding,  the  cytochalasins  reduced  the  number  of 
hormone binding  sites without  altering the  binding  affinities 
(19). 
Concanavalin A has been shown to inhibit the patching and 
capping of immunoglobulin and concanavalin A  receptors on 
lymphocytes (20, 21), and the effects of the lectin are partially 
reversed with colchicine  and vinblastine  (22).  Thus, evidence 
has accumulated  that the structure,  mobility, and availability 
of  surface  receptors  are  dependent  upon  interactions  with 
cytoskeletal elements (23, 24). This property of surface recep- 
tors is evidently shared by the collagen binding site. 
The above-described characteristics of the collagen binding 
reaction are consistent with its participation in some phase of 
the extracellular maturation of collagen. A circumstantial case 
has been made for the  binding  reaction  as an initiating  and 
controlling  event  in  the  assembly  of collagen  molecules  into 
fibrils  (2). The central idea of the proposal is that the binding 
of procollagen or collagen  molecules to a  plasma membrane 
component segregates the collagenous molecules and helps to 
determine  the  spatial  specificity  of their  assembly.  Ligand- 
ligand interactions are thought to play a role in the detachment 
of the molecular aggregates from the cell surface, and the local 
concentration of soluble detached polymers could modulate, in 
turn,  the number, size and off-rates of surface-bound units. 
Although helical filaments will form "spontaneously" from 
pure solutions  of collagen,  actin,  tubulin,  keratin,  and chro- 
matin, the bonding properties of the respective subunits do not 
uniquely specify the geometry of packing in the filaments (25). 
The argument is made, therefore, that the specificity of packing 
of biological filaments in vivo is critically controlled by inter- 
actions with other cell-associated molecules (26). In that sense, 
microtubule  organizing  centers  are  identified  as  nucleation 
sites for tubulin assembly in the cytoplasm (27), and I propose 
that  the  collagen  binding  site  fulfills  an  analogous  role  for 
collagen fibril assembly at the cell surface. Collagen types I, II, 
and  III  characteristically  form  periodic  fibrils  in  vivo.  The 
periodicity is due to the spatial order of packing in the fibril. 
Only native collagen types II and III inhibit binding to type I 
sites (11),  providing circumstantial  evidence that this binding 
reaction helps to determine the mode of molecular packing in 
periodic collagen fibrils.  A  precedent for cell-surface directed 
growth of biological filaments is provided by studies of cellu- 
lose biogenesis.  In this case, the glucan polymers with a char- 
acteristic  parallel-chain  crystalline  lattice elongate from com- 
plexes in the plasma membrane of higher plants and algae (28, 
29), or they are extruded from the lipopolysaccharide wall of 
bacteria (30). 
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